reserpine has been researched along with enalapril in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dworkin, LD; Feiner, HD; Grosser, M; Parker, M; Ullian, M | 1 |
| Fogo, A; Ichikawa, I; Ikoma, M; Kawamura, T; Yoshida, Y | 1 |
| Tomov, I | 1 |
| Chiou, XC; Owens, R; Raij, L; Wrigley, B | 1 |
| Anderson, S; Brenner, BM; Rennke, HG | 1 |
| Naish, PF; Odum, J; Purkiss, J | 1 |
| Baba, N; Sakemi, T | 1 |
| Fukui, M; Sekizuka, K; Shirato, I; Shou, I; Suzuki, S; Tomino, Y; Wang, LN; Yamamoto, M | 1 |
| Griebenow, R; Mueller, E; Mutschler, E; Pittrow, DB; Weidinger, G; Welzel, D | 1 |
| Armini, L; Bardelli, M; Calci, M; Campanacci, L; Candido, R; Carretta, R; Fabris, B; Fazio, M; Fischetti, F | 1 |
| Bidani, AK; Griffin, KA; Picken, MM | 1 |
| Leong, PK; McDonough, AA; Yang, LE | 1 |
| Brusco, I; Justino, AB; Machado-de-Ávila, RA; Oliveira, SM; Scussel, R; Silva, CR | 1 |
2 review(s) available for reserpine and enalapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New trends in the treatment of moderate arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Captopril; Combined Modality Therapy; Coronary Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Hypokalemia; Male; Methods; Middle Aged; Reserpine; Risk | 1986 |
1 trial(s) available for reserpine and enalapril
| Article | Year |
|---|---|
Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clopamide; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Reserpine | 1997 |
14 other study(ies) available for reserpine and enalapril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.
Topics: Animals; Antihypertensive Agents; Captopril; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Renal Circulation; Reserpine | 1989 |
Effects of antihypertensive drugs on glomerular morphology.
Topics: Animals; Antihypertensive Agents; Enalapril; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hydralazine; Hydrochlorothiazide; Hypertrophy; Kidney Glomerulus; Male; Rats; Renal Circulation; Reserpine | 1989 |
Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
Topics: Animals; Enalapril; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR; Reserpine | 1985 |
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; Microcirculation; Natriuresis; Proteinuria; Rats; Renin; Renin-Angiotensin System; Reserpine | 1986 |
Influence of differing classes of antihypertensive agents on mesangial kinetics following partial renal ablation in rats.
Topics: Albuminuria; Animals; Antihypertensive Agents; Biological Transport, Active; Enalapril; Glomerular Mesangium; Hydralazine; Hydrochlorothiazide; Hypertrophy; Kidney Glomerulus; Kinetics; Male; Nephrectomy; Rats; Rats, Wistar; Reserpine; Serum Albumin, Bovine; Tissue Distribution | 1994 |
Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats.
Topics: Animals; Antihypertensive Agents; Cholesterol; Drug Therapy, Combination; Enalapril; Hydralazine; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; Proteinuria; Rats; Reserpine; Time Factors | 1993 |
Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Creatinine; Enalapril; Glomerulonephritis; Hydralazine; Hydrochlorothiazide; Imidazoles; Kidney; Kidney Glomerulus; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Reserpine; Tetrazoles | 1997 |
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Diuretics; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertrophy; Kidney; Male; Proteinuria; Rats; Rats, Inbred SHR; Reserpine; Sodium Chloride Symporter Inhibitors | 1999 |
Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Glomerulosclerosis, Focal Segmental; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Male; Monitoring, Physiologic; Nephrectomy; Rats; Rats, Sprague-Dawley; Reserpine; Telemetry | 2004 |
Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Cortex; Kidney Medulla; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Reserpine; Sodium; Sodium Chloride Symporters; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins, Type II; Sodium-Potassium-Chloride Symporters | 2007 |
Inhibitors of angiotensin I converting enzyme potentiate fibromyalgia-like pain symptoms via kinin receptors in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Captopril; Disease Models, Animal; Enalapril; Fibromyalgia; Male; Mice; Nervous System; Nociceptive Pain; Pain Threshold; Peptidyl-Dipeptidase A; Receptors, Bradykinin; Reserpine; Signal Transduction | 2021 |